eyestock logo

eyestock

Markets
Catalog
Exchange: XNAS
Sector: Healthсare
Ticker: ARCT

AR

Arcturus Therapeutics Holdings IncNASDAQ ARCT Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

—

Market cap $B

0.556

Micro

Exchange

XNAS - Nasdaq

View Full Company Analysis

Return on assets ROA

-17 %

Last period ROA

9%

ROA has increased in 5 years

‌

What is ROA ?

The return on assets ratio shows how much net income a company earns per unit of assets.

See also Arcturus Therapeutics

Company Analysis

ARCT valuation, rating, competitors, insights and company profile

Eyestock Rating

ARCT financial analysis by Eyestock methodology

Valuation

ARCT valuation using historical relative method

Statements

ARCT Income Statements, Balance Sheet and Cash Flow Statements

Dividends

ARCT dividend yield and annual dividend

What is ROA ?

The return on assets ratio shows how much net income a company earns per unit of assets.

What is ROA of Arcturus Therapeutics ?

Arcturus Therapeutics`s ROA for the last twelve months ended 2024-06-30 is -17 %

View Full Company Analysis
Watchlist

Discover

Stock AnalysisScreenerPortfolio